US Edition‘This is cruelty’: Senator Baldwin speaks out against NIH cuts
- Senator Tammy Baldwin criticized budget cuts to the National Institutes of Health, calling the action "cruelty," and noted that funding is essential for research on Alzheimer's and cancer treatments.
- Dr. Sterling Johnson stated that NIH funding cuts will delay Alzheimer’s research and clinical trials, resulting in increased healthcare costs.
- Dr. Larry Saltzman expressed that the proposed cuts represent a significant setback for medical research and future cancer therapies, urging Congress to reject the reductions.
- Several groups have legally challenged the NIH cuts, and a federal judge in Massachusetts has temporarily blocked them.
15 Articles
15 Articles
NIH Cuts Absorbable Without Hobbling Research in Higher Education: Policy Experts
Dozens of prestigious universities sounded the alarm after the National Institutes of Health (NIH) capped overhead costs of taxpayer-funded research grants at 15 percent to reduce government spending. These cuts undermine decades of progress in cancer, Alzheimer’s, and diabetes research, higher education officials announced. Jobs will be eliminated, fewer doctorate students will be admitted to top learning institutions, and marginalized communit…
MedPage Today
Anti-Aging, Acupuncture and Health NewsNIH Cuts Will Devastate Disease Research, Say Senators and Scientists
(MedPage Today) -- The Trump administration's cancellation of NIH funding for clinical trials in cancer and other diseases could have disastrous consequences for patients, according to clinicians and lawmakers who spoke at a Capitol Hill event...
Democratic Sens. joins researchers and patients to denounce NIH cuts
Democratic senators turned to researchers and disease patients on Capitol Hill Wednesday afternoon to learn more about the impact of Trump administration’s efforts to cut health research funding at the National Institutes of Health (NIH).
Coverage Details
Bias Distribution
- 43% of the sources lean Left, 43% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
